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Abstract
Introduction
Evaluations of weight management programs in real-
world settings are lacking. The RE-AIM model (reach, 
effectiveness, adoption, implementation, maintenance) 
was developed to address this deficiency. Our primary 
objective was to evaluate a 12-week insurance-sponsored 
weight management intervention by using the RE-AIM 
model, including short-term and long-term individual 
outcomes and setting-level implementation factors. Our 
secondary objective was to critique the RE-AIM model and 
its revised calculation methods.
Methods
We created operational definitions for components of the 
5 RE-AIM indices and used standardized effect size values 
from various statistical procedures to measure multiple 
components or outcomes within each index. We used χ2 
analysis to compare categorical variables and repeated-
measures analysis of variance to assess the magnitude of 
outcome changes over time.
Results
On the basis of data for 1,952 participants and surveys 
completed by administrators at 23 sites, RE-AIM indices 
ranging from 0 to 100 revealed low program reach and 
adoption (5.4 and 8.8, respectively), moderate effective-
ness (43.8), high implementation (91.4), low to moderate 
individual maintenance (21.2), and moderate to high site 
maintenance (77.8). Median (interquartile range) weight 
loss was 13 lb (6.5-21.4 lb) among participants who com-
pleted phase I (12 weeks; 76.5%) and 15 lb (6.1-30.3 lb) 
among those who completed phase II (1 year; 45.7%).
Conclusions
This program had a significant, positive effect on partici-
pants and has been sustainable but needs to be expanded 
for more public health benefit. The RE-AIM model pro-
vided a useful framework to determine program strengths 
and weaknesses and to present them to the insurance 
agency and public health decision makers.
Introduction
Regardless of the success of diet and physical activity 
programs in controlled research settings (1-6), if large-
scale programs are not effective or easily implemented 
in real-world settings they fall short of their intended 
purpose. In the Strategic Plan for NIH Obesity Research, 
the National Institutes of Health Obesity Research Task 
Force (7) outlined a national strategy for obesity research 
emphasizing the use of translational research. However, 
evaluation of the translation of effective programs to real-
world settings is lacking (8).
The RE-AIM model (9) was developed as a tool to 
evaluate health promotion programs along 5 dimen-
sions: reach, effectiveness, adoption, implementation, and 
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maintenance. Reach refers to the percentage of potential 
participants who enroll and their representativeness of 
the target population; effectiveness, to the changes in 
participant outcomes during the program; adoption, to the 
number and representativeness of sites willing to conduct 
the program; implementation, to site adherence to pro-
gram protocols; and maintenance, to individual outcomes 
after final intervention contact and program continuation 
at sites over the long term (8-10).
The RE-AIM model has been used to evaluate a limited 
number of programs, including 14 WISEWOMAN cardio-
vascular screening interventions in North Carolina (11), 
a church-based physical activity intervention in South 
Carolina (12), and 2 diabetes self-management interven-
tions (13). To our knowledge, no evaluation of a large-scale 
weight management program using RE-AIM methods 
has been published, but studies have shown the model is 
applicable to a variety of health behaviors and programs. 
Additionally, researchers have recommended revising RE-
AIM index calculation methods to reduce the likelihood of 
difficult-to-interpret negative values (13).
Our primary objective was to use RE-AIM to evaluate 
a multisite, insurance-sponsored weight management 
program that produced positive short-term physical and 
psychosocial changes in participants in a university labo-
ratory setting. Our secondary objective was to critique 
the RE-AIM model’s usefulness as an evaluation tool for 
health promotion programs. We analyzed 3- and 12-month 
participant outcomes and site-level program implementa-
tion information.
Methods
This study evaluated a weight management program 
that has been offered since 2004 by a large public employ-
ees’ insurance agency in West Virginia as a benefit to its 
members. Obese insured members (body mass index [BMI] 
≥30 kg/m2) are eligible for the program, as are overweight 
members (BMI 25.0-29.9 kg/m2) who also report being 
treated for hypertension, diabetes, heart disease, meta-
bolic syndrome, or sleep apnea. Participants enroll in the 
program by calling the insurance agency to be screened 
for height, weight, and health information and must have 
written approval from their primary care physician.
The insurance agency also screens site providers to 
ensure the site has adequate safety devices, exercise 
equipment, and staffing to accommodate high-risk par-
ticipants. At the time of this study, the insurance agency 
had approved 31 fitness facilities (“sites”) to accept par-
ticipants: 2 housed in university cardiac rehabilitation/
exercise physiology laboratories, 2 in physical therapy 
facilities, 5 in hospitals, and 22 private wellness/fitness 
centers. Searches of available print (14) and online (www.
wvha.com, www.yellowpages.com) resources yielded 352 
of these types of facilities in West Virginia. Each approved 
site is required to designate an administrator to act as liai-
son with the insurance agency, handle participant contact, 
coordinate site services, and enter participant data into a 
database.
The weight management program evaluated in this 
study is a 1-year benefit, during which weight loss is pro-
moted by using a combination of behavior therapy (eg, food 
logs), individualized site-based exercise programming, and 
individualized diet therapy. Case management nurses 
track participant progress on the basis of monthly entry of 
the following body measurements by the sites into a Web-
based database: weight and BMI, systolic and diastolic 
blood pressure, body fat percentage, waist circumference, 
and number of site visits. Each site determines its mea-
surement protocols on the basis of available instruments 
and staff training. Sites are compensated via monthly 
member copayments and insurance agency payments for 
the provision of on-site services in 2 phases.
Phase I (months 1-3)
Services provided during phase I include 1) access to 
the exercise site, 2) a 60-minute fitness evaluation and 
exercise program designed by an exercise physiologist, 3) 
a 60-minute evaluation and nutrition program designed 
by a registered dietitian, 4) monthly 30-minute exercise 
sessions with a personal trainer, and 5) 60-minute fol-
low-up reassessments by the exercise physiologist and 
registered dietitian at the end of month 3. Participants 
may be removed from the program if they fail to exercise 
at the site at least twice per week; turn in food logs peri-
odically; attend appointments with the exercise physiolo-
gist, registered dietitian, or personal trainer; or have body 
measurements taken by site staff monthly. Phase I is 
considered the “intervention” period for this evaluation. 
If participants meet the behavioral requirements and lose 
12 lb (or show substantial improvements in other physical 
measures) they may continue to phase II.
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Phase II (months 4-12)
Phase II spans the remainder 
of the first year (9 months). This 
phase is considered the postint-
ervention period for the current 
evaluation because it is more 
like a private gym membership 
than a weight-loss intervention; 
it provides access to the facility 
and 1 personal training session 
per month. Participants are 
expected to continue exercising 
at the facility twice per week 
and have physical measure-
ments and visit data submitted 
monthly by the sites to main-
tain the benefit.
The insurance agency dic-
tates what services are offered, 
but not how the services are 
implemented. The use of rel-
evant weight management 
guidelines of the American 
College of Sports Medicine 
(ACSM) (15) and the American 
Dietetic Association (16) is sug-
gested. For example, the exer-
cise physiologist may choose from fitness testing methods 
recommended by ACSM (eg, 6-minute walk test, 1-mile 
walk test) and the registered dietitian may use his or her 
discretion in diet composition or outcome goals.
Data sources
We used archival participant data and site administra-
tor surveys to evaluate the weight management program. 
The insurance agency granted us access to an online 
password-protected database containing demographic and 
physical measurement data of all program participants. 
The university’s institutional review board approved the 
study for the protection of human participants. We down-
loaded, verified, de-identified, and imported archival data 
of all participants into SPSS version 14.0 (SPSS, Inc, 
Chicago, Illinois).
To gather site-level program evaluation data, we recruit-
ed site administrators by mail, e-mail, and telephone (17) 
to complete an online survey. 
The survey assessed 1) site 
staffing, equipment, and facil-
ities; 2) program implementa-
tion methods; and 3) barri-
ers to program implementa-
tion. Section 2 of the survey 
was relevant to this study; 
it included items that ascer-
tained the procedures (open-
ended) or frequency (categori-
cal) of conducting 14 program 
components during phase I as 
recommended or required by 
the insurance agency: mea-
suring weight, waist circum-
ference, body fat percentage, 
and blood pressure; providing 
individualized nutrition and 
fitness assessments, nutrition 
classes, fitness plan, one-on-
one personal training, and fol-
low-up nutrition and fitness 
assessments; tracking partici-
pant attendance; and review-
ing home exercise and food 
logs or journals. Responses 
were recoded to dichotomous 
variables (yes/no) and the sum 
of yes responses tallied to represent the number of pro-
gram components implemented.
Statistical analyses of RE-AIM indices
Presenting results using the RE-AIM model first 
requires creating operational definitions for multiple com-
ponents in each of the 5 RE-AIM dimensions (10) (Box). 
These components were used to calculate RE-AIM indices 
(Appendix). Index calculations used standardized effect 
size (18) values from various statistical procedures to 
measure multiple components or outcomes in each index. 
We used χ2 analysis to compare categorical variables 
and repeated measures analysis of variance (ANOVA) to 
assess the magnitude of outcome changes over time. In 
the indices, “positive” effects were reduced by differential 
or “negative” effects (eg, program attrition). This index 
calculation method has resulted in negative values in 
prior studies (13) for 2 reasons. First, in calculating index 
values, differential effects have been subtracted directly 
Box. RE-AIM Components and Operational Definitions
RE-AIM Component Definition
Individual participation 
rate (IPR)
The percentage of eligible members of the 
insurance agency who participated in the 
weight management program
Demographic repre-
sentativeness (DR)
How well participants represented the 
population eligible for the program
Individual completion 
rate (ICR)
The percentage of participants who com-
pleted each of the phases of the weight 
management program
Outcomes (O) Weight change experienced by completers 
of each phase of the weight management 
program
Differential impact (DI) A measure of differential changes in 
weight experienced among phase I and II 
completers by sex and age
Setting participation 
rate (SPR)
The percentage of eligible cardiac reha-
bilitation centers, physical therapy clinics, 
wellness/fitness centers, and health clubs 
in the state that participated in the weight 
management program
Component implemen-
tation rate (CIR)
The percentage of program protocols 
implemented at each site
Setting continuation 
rate (SCR)
The percentage of program sites that 
have elected to continue conducting the 
program for more than 1 year
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from outcome effects, overstating the “negative” program 
effect. To limit this potential distortion, we calculated a 
“proportion of positive effect not explained by differential 
effects” by first subtracting the differential (“negative”) 
effect size from 1 and then multiplying the difference by 
the “positive” effect (Appendix). Second, a negative index 
value may still result if the effect size is more than 1. 
We resolved this challenge by using effect size measures 
whose upper limit was 1.
Effect size measures (and interpretation) included the 
squared Cramer phi (φc
2) for χ2 tests (small [φc
2 ≈ .01], 
moderate [φc
2 ≈ .09], or large [φc
2 > .25]) and the squared 
curvilinear correlation coefficient (partial eta squared; η2) 
for ANOVA (small [η2 ≈ .01], moderate [η2 ≈ .06], or large 
[η2 > .14]) (18,19). All raw index scores ranging from 0 to 
1 were multiplied by 100 for summary index values of 0 
to 100. Missing data were excluded from analyses, which 
were conducted by using SPSS version 14.0.
Results
The data for 1,952 participants from 31 sites were export-
ed, and administrators from 27 of 31 active sites (87.1% 
response rate) completed online surveys. Responses from 4 
new sites whose participants had not yet completed phase 
I of the program were excluded from analysis, resulting 
in 23 completed site administrator surveys. The distribu-
tion of most of the participants’ measurement data was 
skewed, and data are presented as median (interquartile 
range) unless otherwise noted.
Individual-level impact ([reach * effectiveness] / 100)
A total of 60,041 adult members were covered by the 
insurance agency (N. Henderson, health promotions direc-
tor, written communication, January 2008). By using the 
state obesity (31%) and overweight (36%) prevalence rates 
(20), and national prevalence of overweight adults with at 
least 1 comorbid condition (66%) (21), we estimated that 
32,878 insurance members may have been eligible for 
the program. At the time of data collection, 1,952 mem-
bers had participated (5.9% individual participation rate) 
(Table 1).
Baseline physical measurements for men and women 
are presented in Table 2. A significantly larger percentage 
of participants than the eligible population were women 
(80.0% vs 54.1%; P < .001, φc2 = .073), and more of them 
were aged 45-54.9 years and fewer of them were aged 65 
years or older (P < .001, φc2 = .113), yielding a reach value 
(R) of 5.4 (Table 1).
Phase I outcome changes are presented in Table 3. Of 
1,647 participants who could have completed phase I (those 
who had started the program at least 12 weeks before data 
collection), 76.5% had done so. Fewer women (74.8%) than 
men (83.7%) completed phase I (P = .001, φc2 = .007), and 
completion rates tended to rise with age. Participants who 
completed phase I had significant weight loss (13 lb [6.5-
21.4 lb]; P < .001, η2 = .592), and men lost significantly 
more weight than women (P < .001, η2 = .050). Differences 
in weight loss were also revealed among age groups (P = 
.003, η2= .014). These components produced an effective-
ness value (E) of 43.8 and an individual-level impact ([R * 
E] / 100) of 2.4 (Table 1).
Setting-level impact ([adoption * implementation] / 100)
There were 31 active weight management program sites 
out of a total of 352 potential sites in West Virginia at the 
time of data collection, resulting in an adoption value (A) 
of 8.8 (Table 1). Site survey responses (N = 23) showed 
that sites implemented a mean of 12.8 (standard devia-
tion [SD] 1.0) of 14 program components during phase I. 
All sites measured weight, waist circumference, body fat 
percentage, and blood pressure; tracked attendance; and 
provided initial and follow-up nutrition assessments with 
a registered dietitian, nutrition classes designed by the 
registered dietitian, and an individualized exercise pre-
scription. The least frequently implemented component, 
by 15 sites (65%), was having participants maintain home 
exercise logs. Implementation survey data yielded an 
implementation value (I) of 91.4 and a setting-level impact 
([A * I] / 100) of 8.0 (Table 1).
Long-term maintenance ([individual maintenance *  
setting maintenance] / 100)
Phase II outcome changes are presented in Table 4. Of 
762 participants who could have completed phase II (those 
who had started the program at least 1 year before data 
collection), 348 (45.7%) had done so (ICRPhII = .457) (Table 
1). Excluding the small samples of participants aged 18-
24.9 years (n = 2) and 65 years or older (n = 9), completion 
rates tended to increase with age and be higher in men 
in each age group. Participants who completed phase II 
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achieved significant weight loss from baseline (15 lb [6.1-
30.3 lb]; P < .001, η2 = .467), shedding 6.7% (2.7%-12.7%) 
of baseline body weight. Weight loss was similar among 
phase II completers of different age groups (P = .61, η2 = 
.011) and between sexes (P = .21, η2 = .005). These values 
combined to yield an individual maintenance value (MI) of 
21.2 (Table 1).
Four of 18 sites (22%) that had been approved to accept 
participants at least 1 year before this study had stopped 
or had been disallowed to continue accepting participants, 
resulting in a setting maintenance value (MS) of 77.8 and 
a long-term maintenance value ([MI * MS] / 100) of 16.5 
(Table 1).
Discussion
We achieved our primary objective of using RE-AIM 
to evaluate a weight management program. We found 
moderate program effectiveness and high implementa-
tion, suggesting the program has been beneficial for 
participants and can be implemented in a variety of 
settings. We found low program reach and adoption, sug-
gesting the program could be improved by recruiting new 
participants and sites. Recruitment may prove difficult, 
however, because participants must be highly motivated 
to enroll in the program, and sites are required to offer 
services by highly trained personnel often unavailable 
in rural areas of West Virginia. In the long term, site 
maintenance was high, but individual maintenance was 
fairly low, indicating the program is sustainable but the 
services of phase II may need to be revised to improve 
participant outcomes. The summary results suggest 
this weight management program has potential to be 
expanded for more translation and public health benefit 
and should be considered a viable model for other public 
and private insurers.
Individual short-term and long-term outcome changes 
are comparable with those of other behavioral programs 
and clinical trials. Short-term attrition from this weight 
management program (23.5%) was slightly higher than is 
commonly seen in behavioral programs of similar length 
(10%-15%), though the median weekly weight loss in this 
program is comparable (1.23 lb vs 1.1 lb) (22). This pro-
gram also compares favorably with clinical trials of simi-
lar length, which average 85%-95% completion rates and 
approximately 1 lb of weekly weight loss (1,5).
Long-term individual results also compare favor-
ably with other behavioral programs and clinical trials. 
Participants who completed phase II (n = 348) lost a mean 
of 20.9 (SD, 22.3) lb from baseline, with some recidivism. 
Slightly more than half of phase II completers (51.5%) 
maintained phase I weight loss or continued losing weight 
in phase II. In comparison, approximately 60% to 70% of 
weight loss is maintained for a year after treatment in 
other short-term behavioral interventions (22). One-year 
results indicate more average weight losses but lower 
completion rates than randomized control trials of similar 
length (1,5).
We also achieved the secondary objective of critiquing 
the RE-AIM model and revised index calculations. The 
strength of the RE-AIM model is its ability to quantify for 
decision makers a program’s strengths and weaknesses. 
Comparison with other health promotion program evalu-
ations that used RE-AIM is limited at this point in the 
model’s refinement because no 2 studies have used the 
same index calculation methods. We believe this study 
advances the RE-AIM model by 1) providing methods for 
assessing long-term maintenance at the individual and 
site levels and 2) addressing 2 methodologic concerns with 
existing index calculation methods (ie, negative index val-
ues and effect sizes with varying maximum values). The 
revised methods in this study produced positive R and MI 
values, whereas previously used methods (10) would have 
yielded negative values.
Limitations
The study is limited in a number of ways. Multiple 
sources of measurement error may have affected the 
data, including 1) lack of standardized procedures and 
instruments for measuring health outcomes, 2) missing 
outcome data, and 3) social desirability of sites when 
entering participant data and completing survey items. 
Potential error was addressed in multiple ways. Trained 
exercise professionals took measurements using accepted 
professional standards of practice, the insurance agency 
periodically audited site data, we contacted sites to collect 
missing data, and all survey recruiting material stressed 
the informative (not punitive) nature of the study and 
independence of the investigators from the insurance 
agency. Measurement error would be more important in 
a small clinical trial assessing an intervention’s efficacy 
than in this study with its large sample and focus on stan-
dardized effect sizes.
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Conclusions
Numerous questions remain to be answered before the 
public health effect of this and other weight management 
programs can be better understood. This program had a 
significant positive effect on participants and was sustain-
able, but needs to be expanded. The RE-AIM model pro-
vided a framework through which the translation of this 
program could be evaluated and presented to public health 
decision makers. In fact, the summary data of this project 
were presented to the insurance agency and used as evi-
dence for changing the program benefit to address the low 
reach, adoption, and long-term individual maintenance. 
We encourage continued study of RE-AIM index calcula-
tions and application of the model to evaluate obesity 
treatment programs. It may be beneficial to add qualita-
tive process data to these outcomes to work toward devel-
oping a set of best practices in behavioral weight manage-
ment (11,12). Additionally, because insurance agencies 
often provide benefits for multiple weight management 
modalities (eg, behavioral, surgical, pharmacologic), RE-
AIM methods should be used to evaluate multiple modali-
ties concurrently to allow for side-by-side comparison and 
facilitate decision making about resource allocation. These 
evaluations will need to link program costs, insurance 
claims, individual outcomes, and future cost savings. Such 
analyses may affect the benefit and incentive structure 
of this insurer and others to improve the translation of 
knowledge regarding clinical obesity treatment into inno-
vative programming that can be widely implemented.
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Tables
Table 1. RE-AIM Model Component and Index Values Used to Evaluate a Weight Management Program, West Virginia, 2004
Component RE-AIM Index Valuea
Individual participation rate (IPR)  IPR = 1,92 / 60,041 * (.31 + [.36 * .66])
IPR = .09
Demographic representativeness (DR)  DR = (.073 + .113) / 2 
DR = .093
 Reach (R) R = (.059 * [1 – .093]) * 100 
 
R = 5.4
Phase I individual completion rate (ICRPhI)  ICRPhI = 1,260 / 1,647 
ICRPhI = .76
Phase I outcome (OPhI)  OPhI = .92
Phase I differential impact (DIPhI)  DIPhI = (.00 + .014) / 2 
DIPhI = .032
 Effectiveness (E) E = (.765 * .592 * [1 - .032]) * 100 
 
E = 43.8
Setting participation rate (SPR)  SPR = 31 / 32
SPR = .0
 Adoption (A) A = (.088 * 100) = 8.8
Component implementation rate (CIR)  CIR = 12. / 14 
CIR = .914
 Implementation (I) I = (.914 * 100) = 91.4
Phase II individual completion rate (ICRPhII)  ICRPhII = 34 / 762 
ICRPhII = .47
Phase II outcome (OPhII)  OPhII = .467
Phase II differential impact (DIPhII)  DIPhII = (.00 + .011) / 2 
DIPhII = .00
 Individual maintenance (MI) MI = (.457 * .467 * [1 - .008]) * 100 
 
MI = 21.2
Setting continuation rate (SCR)  SCR = 14 / 1 
SCR = .77
 Setting maintenance (MS) MS = (.778 * 100) = 77.8
 
Abbreviation: RE-AIM, reach, effectiveness, adoption, implementation, maintenance. 
a Methods of calculating the values are described in the Appendix.
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Table 2. Baseline Measurements of Participants, Weight Management Program, West Virginia, 2004
Measurement
Women (n = 1,561) Men (n = 391)
No.a Median (IQR)b No.a Median (IQR)b
Age, y 1, 49.7 (41.7 to .) 391 1. (43.0 to 7.)
Height, in 1,7 64.0 (63.0 to 66.0) 390 71.0 (69.0 to 73.0)
Weight, lb 1,42 220. (192.0 to 2.4) 34 269.9 (232.7 to 333.)
BMI, kg/m2 1,426 3. (32. to 43.1) 33 37.6 (32. to 44.)
Systolic blood pressure, mm Hg 1,39 126.0 (11.0 to 136.0) 330 130.0 (120.0 to 140.0)
Diastolic blood pressure, mm Hg 1,39 0. (9.9)c 330 2.1 (9.)c
Body fat, % 1,193 4.9 (41.9 to 49.4) 302 36.1 (31.6 to 42.)
Waist, in 73 43.0 (3.6 to 47.) 226 47.4 (43. to 3.0)
 
Abbreviations: IQR, interquartile range; BMI, body mass index. 
a Sample sizes vary because of missing data for some measurements. 
b Median and IQR are presented for data with skewed distributions unless otherwise noted. 
c Measurement has a normal distribution and is presented as mean (standard deviation). 
Table 3. 12-Week Measurements and Changes From Baseline of Phase I Completers, Weight Management Program, West 
Virginia, 2004a
Measurement
Phase I Completers 
(n = 1,260, 76.5%)
End Phase I Change From Baseline
No.b Median (IQR)c No.b Median (IQR)c
Women (n = 993; 74.8% completion rate)
Weight, lb 971 20.4 (179.0 to 242.) 970 −12.0 (−19.8 to −6.0)
Weight, % NA NA 970 −5.5 (−8.7 to −2.8)
BMI, kg/m2 971 34.6 (30.9 to 40.0) 970 −2.1 (−3.3 to −1.0)
Systolic blood pressure, mm Hg 769 122.0 (113.0 to 130.0) 764 −5.0 (16.1)d
Diastolic blood pressure, mm Hg 769 77.1 (.9)d 764 −3.4 (10.5)d
Body fat, % 04 43. (39.7 to 47.9) 740 −2.0 (3.2)d
Waist, in 690 39.9 (36.0 to 44.0) 14 −2.5 (−4.1 to −1.5)
 
Abbreviations: IQR, interquartile range; NA, not applicable; BMI, body mass index. 
a 1,647 participants could have completed phase I. 
b Sample sizes vary because of missing data for some measurements; negative change values indicate improvements from baseline to the end of phase I (12 
weeks). 
c Median and IQR are presented for data with skewed distributions unless otherwise noted. 
d Measurement has a normal distribution and is presented as mean (standard deviation).
(Continued on next page)
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Measurement
Phase I Completers 
(n = 1,260, 76.5%)
End Phase I Change From Baseline
No.b Median (IQR)c No.b Median (IQR)c
Men (n = 267; 83.7% completion rate)
Weight, lb 263 21. (219. to 30.) 263 −16.9 (−29.3 to −8.0)
Weight, % NA NA 263 −6.1 (−10.2 to −3.0)
BMI, kg/m2 263 3.1 (30. to 41.3) 262 −2.3 (−3.9 to −1.1)
Systolic blood pressure, mm Hg 223 124.0 (117.0 to 132.0) 213 −7.3 (13.6)d
Diastolic blood pressure, mm Hg 223 76.9 (.7)d 213 −4.6 (9.7)d
Body fat, % 214 33.0 (29.1 to 39.0) 199 −3.6 (4.9)d
Waist, in 199 4.0 (41.0 to 0.) 14 −2.5 (−4.4 to −1.3)
 
Abbreviations: IQR, interquartile range; NA, not applicable; BMI, body mass index. 
a 1,647 participants could have completed phase I. 
b Sample sizes vary because of missing data for some measurements; negative change values indicate improvements from baseline to the end of phase I (12 
weeks). 
c Median and IQR are presented for data with skewed distributions unless otherwise noted. 
d Measurement has a normal distribution and is presented as mean (standard deviation).
Table 4. One-Year Measurements and Changes From Baseline of Phase II Completers, Weight Management Program, West 
Virginia, 2004a
Measurements
Phase II Completers 
(n = 348, 45.7%)
End Phase II Change From Baseline
nb Median (IQR)c nb Median (IQR)c
Women (n = 257; 39.5% completion rate)
Weight, lb 21 196.0 (173.4 to 227.4) 21 −15.3 (−28.6 to −6.3)
Weight, % NA NA 21 −7.1 (−12.5 to −3.1)
BMI, kg/m2 21 32.7 (29. to 3.2) 21 −2.6 (−4.8 to −1.1)
Systolic blood pressure, mm Hg 199 123. (12.7)d 197 −5.3 (17.0)d
Diastolic blood pressure, mm Hg 199 7.7 (.)d 197 −6.3 (11.2)d
Body fat, % 216 42. (6.0)d 1 −2.7 (4.5)d
Waist, in 193 3.0 (3.4 to 41.9) 113 −4.0 (−6.4 to 2.0)
 
Abbreviations: IQR, interquartile range; NA, not applicable; BMI, body mass index. 
a 762 participants could have completed phase II. 
b Sample sizes vary because of missing data for some measures; negative change values indicate improvements from baseline to the end of phase II (1 year). 
c Median and IQR are presented for data with skewed distributions unless otherwise noted. 
d Measurement has a normal distribution and is presented as mean (standard deviation).
Table 3. (continued) 12-Week Measurements and Changes From Baseline of Phase I Completers, Weight Management 
Program, West Virginia, 2004a
(Continued on next page)
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Measurements
Phase II Completers 
(n = 348, 45.7%)
End Phase II Change From Baseline
nb Median (IQR)c nb Median (IQR)c
Men (n = 91; 51.4% completion rate)
Weight, lb  24. (217. to 29.2)  −14.8 (−36.3 to −5.2)
Weight, % NA NA  −5.4 (−12.9 to −1.8)
BMI, kg/m2  34.6 (30.1 to 39.)  −2.1 (−5.1 to −0.7)
Systolic blood pressure, mm Hg 67 12.7 (14.1)d 6 −7.1 (14.7)d
Diastolic blood pressure, mm Hg 67 76.6 (10.)d 6 −6.4 (10.4)d
Body fat, % 64 33.2 (6.)d 6 −2.9 (6.6)d
Waist, in 60 43.3 (3. to 0.0) 37 −3.0 (−5.1 to −1.6)
 
Abbreviations: IQR, interquartile range; NA, not applicable; BMI, body mass index. 
a 762 participants could have completed phase II. 
b Sample sizes vary because of missing data for some measures; negative change values indicate improvements from baseline to the end of phase II (1 year). 
c Median and IQR are presented for data with skewed distributions unless otherwise noted. 
d Measurement has a normal distribution and is presented as mean (standard deviation).
Appendix. RE-AIM Components, Indices, and Calculation Equations
Component RE-AIM Index Calculation Equation
Individual participation rate (IPR)  No. of participants / no. of adult insurance agency members * (state’s adult obesity preva-
lence rate + [state’s adult overweight prevalence rate * overweight with at least 1 comor-
bid condition national prevalence rate])
Demographic representativeness 
(DR)
 Mean ES (φc
2) of sex- and age-bracket χ2 comparisons of program participants and state 
residents
 Reach (R) R = (IPR * [1 – DR]) * 100
Phase I individual completion rate 
(ICRPhI)
 No. of phase I completers / no. participants who could have completed phase I
Phase I outcome (OPhI)  ES (η
2) from 1-way RM ANOVA (IV: time; DV: weight among phase I completers)
Phase I differential impact (DIPhI)  Mean ES (η
2) from two 2-way RM ANOVAs: 1) IVs: time x age bracket; DV: weight among 
phase I completers, and 2) IVs: time x sex; DV: weight among phase I completers
 Effectiveness (E) E = (ICRPhI * OPhI * [1 – DIPhI]) * 100
Setting participation rate (SPR)  No. of active sites / (no. of cardiac rehabilitation centers + no. of physical therapy clinics + 
no. of hospitals + no. of wellness/fitness centers + no. of health clubs in the state)
 
Abbreviations: ES, effect size; φc
2, squared Cramer phi; η2, partial eta squared; RM ANOVA, repeated measures analysis of variance; IV, independent variable; 
DV, dependent variable.
Table 4. (continued) One-Year Measurements and Changes From Baseline of Phase II Completers, Weight Management 
Program, West Virginia, 2004a
(Continued on next page)
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Component RE-AIM Index Calculation Equation
 Adoption (A) A = SPR * 100
Component implementation rate 
(CIR)
 Mean no. of “yes” responses to “Program Components” section of site survey / 14
 Implementation (I) I = CIR * 100
Phase II individual completion rate 
(ICRPhII)
 No. of phase II completers / no. of participants who could have completed phase II
Phase II outcome (OPhII)  ES (η
2) from 1-way RM ANOVA (IV: time; DV: weight among phase II completers)
Phase II differential impact (DIPhII)  Mean ES (η
2) from two 2-way RM ANOVAs: 1) IVs: time x age bracket; DV: weight among 
phase II completers, and 2) IVs: time x sex; DV: weight among phase II completers
 Maintenance: indi-
vidual (MI)
MI = (ICRPhII * OPhII * [1 – DIPhII]) * 100
Setting continuation rate (SCR)  No. of active sites that have continued to offer the program for 1 year or longer / no. of 
sites that started offering the program 1 year or more before study
 Maintenance: setting 
(MS)
MS = SCR * 100
 
Abbreviations: ES, effect size; φc
2, squared Cramer phi; η2, partial eta squared; RM ANOVA, repeated measures analysis of variance; IV, independent variable; 
DV, dependent variable.
Appendix. (continued) RE-AIM Components, Indices, and Calculation Equations
